Disorder of carnitine cycle and carnitine transport
MONDO:00177164 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsSub-types
Broader categories
-
New hope for rare metabolic disease patients: expanded access to triheptanoin
Disease control Expanded accessThis program provides expanded access to triheptanoin for people with long-chain fatty acid oxidation disorders (LC-FAOD) who have few treatment options and cannot join a clinical trial. The goal is to help manage the disease by providing an alternative energy source for the body…
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a simple supplement ease heart failure?
Symptom relief Recruiting nowThis study tests whether taking L-carnitine, a natural substance that helps turn fat into energy, can improve symptoms and quality of life in people with heart failure and kidney problems. About 20 adults will take the supplement for a short time while researchers monitor side ef…
Early phase 1 • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC